Search

Wright v. Dicampli - Summary Judgment Motion Ruling

The U.S. District Court for the District of Delaware issued a summary judgment motion ruling in Wright v. Dicampli. The court addressed claims of prisoner Franklin Wright against correctional officers regarding alleged Eighth and Fourteenth Amendment violations. The ruling focuses on the defendants' motion for summary judgment.

Edelman Financial Engines v. Prime Capital Investment Advisors - Injunctive Relief Opinion

The U.S. District Court for the District of Delaware issued a memorandum opinion in Edelman Financial Engines v. Prime Capital Investment Advisors. The court granted partial injunctive relief concerning two former Edelman employees who joined Prime Capital, to enforce non-solicitation and confidentiality provisions.

TIR Technologies Ltd. v. Comcast Cable Communications, LLC - Patent Infringement Case Dismissed

The U.S. District Court for the District of Delaware granted a motion to dismiss a patent infringement case filed by TIR Technologies Ltd. against Comcast Cable Communications, LLC and other related entities. The court's opinion and order were dated March 11, 2026.

Pfizer v. Dexcel Pharma Technologies - Court Opinion on Expert Testimony

The US District Court for the District of Delaware denied a motion by Defendants Cipla Limited and Hikma Pharmaceuticals USA Inc. to exclude expert testimony in the patent infringement case Pfizer v. Dexcel Pharma Technologies. The court's memorandum opinion addresses the admissibility of Dr. Adam Matzger's testimony concerning infringement of the '441 patent.

Shelton v. Patton - Motion to Dismiss Opinion

The District of Delaware issued an opinion in Shelton v. Patton, addressing defendants' motions to dismiss all five counts of the plaintiff's complaint. The court is considering whether the complaint states a claim upon which relief can be granted under Federal Rule of Civil Procedure 12(b)(6).

Astellas Pharma Inc. v. Ascent Pharmaceuticals, Inc. - Patent Infringement

The US District Court for the District of Delaware issued a Memorandum and Order in a patent infringement case involving Astellas Pharma Inc. and Ascent Pharmaceuticals, Inc. The case concerns Ascent's Abbreviated New Drug Application (ANDA) for a generic version of Astellas's Myrbetriq® and alleges infringement of several patents under the Hatch-Waxman Act.